Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Learn when to rebuild or rightsize your SOX or internal audit program. Our Second Line Ready series helps you move forward with clarity and purpose.
SOX programs often stall from slow drift and misaligned execution. Weaver’s Second Line Ready series offers a clear path to getting back on track.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
Weaver’s Q2 2025 SEC Update webinar summary covers transfer pricing strategies and financial reporting related to tariffs, as well as upcoming ASUs.
Weaver’s professionals discuss tax legislation and economic trends. Tips for audit and SOX compliance, M&A accounting as well as system implementations.
Although the SEC withdrew its climate disclosure rule, state and international regulations still require businesses to manage emissions and climate risks.
The FASB’s release of ASU 2024-03 is an important part of ensuring transparency and investor confidence when reading financial statements. Learn more.
The SEC’s new regulations for safeguarding crypto assets and the administration’s executive order are changing the landscape for digital assets.
J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.
This webinar summary covers changes to the TCJA, tax rates and credits, new requirements for ASC 280 and ASC 740 and year-end impairment reminders.
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Learn how ASU 2023-09 enhances income tax disclosures with new rate reconciliation and cash flow reporting requirements for public entities.
